Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial (Q39770863)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial |
scientific article |
Statements
1 reference
Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial (English)
1 reference
Michael Boeckh
1 reference
Per Ljungman
1 reference
Hermann Einsele
1 reference
Johan Maertens
1 reference
Drew J Winston
1 reference
Roy F Chemaly
1 reference
Lynne Strasfeld
1 reference
Tulio Rodriguez
1 reference
Michael Schmitt
1 reference
Augustin Ferrant
1 reference
Jeffrey H Lipton
1 reference
Stephen A Villano
1 reference
Hongzi Chen
1 reference
Maribavir 1263-300 Clinical Study Group
1 reference
21 March 2011
1 reference
1 reference
Identifiers
1 reference